Byrne Michael F., Mitchell Robert M., Baillie John
Box 3189, Duke University Medical Center, Durham, NC 27710, USA.
Curr Treat Options Gastroenterol. 2002 Oct;5(5):331-338. doi: 10.1007/s11938-002-0021-2.
Pseudocysts complicate acute pancreatitis in less than 5% of cases and chronic pancreatitis in 20% to 40% of cases. A pseudocyst is a localized collection of pancreatic fluid surrounded by a wall of granulation tissue and collagen. It takes 4 to 6 weeks for a fluid collection to mature and become a true pseudocyst. Unlike other cystic lesions of the pancreas from which they should be differentiated, pseudocysts lack an epithelial layer. Patients with pseudocysts present with a range of symptoms and signs. Pseudocysts are imaged using transabdominal ultrasound, CT, endoscopic ultrasound (EUS), and MRI. EUS confers an advantage over other imaging modalities in that certain EUS features are suggestive of pseudocysts over other cystic lesions. The diagnostic accuracy of EUS has improved further with the use of EUS-guided fine-needle aspiration. Therapeutic options include watchful observation or intervention. In our opinion, if acute pseudocysts are uncomplicated, asymptomatic, and do not appear to be enlarging on serial imaging, it is preferable to withhold intervention because many of these cysts resolve spontaneously. However, one needs to beware of the possibility of complications such as infection in unresolved pseudocysts. Pseudocysts associated with chronic pancreatitis are less likely to resolve spontaneously and are drained by intervention more frequently. Of the three interventional options, namely endoscopic, percutaneous, and surgical drainage, endoscopic drainage should be the treatment of choice if certain criteria are met. Preinterventional endoscopic retrograde cholangiopancreatography is mandatory to define ductal anatomy. If there is communication between the pseudocyst and the pancreatic duct, a transpapillary approach is preferred. Use of EUS should increase the number of cases in which pseudocysts can be drained endoscopically. Surgery should be reserved for cases in which there is a concern about malignancy or when there is glandular disruption.
胰腺假性囊肿在不到5%的急性胰腺炎病例以及20%至40%的慢性胰腺炎病例中会出现并发症。假性囊肿是胰腺液的局部聚集,周围是肉芽组织和胶原壁。液体聚集成熟并成为真正的假性囊肿需要4至6周时间。与需要鉴别的胰腺其他囊性病变不同,假性囊肿没有上皮层。假性囊肿患者会出现一系列症状和体征。可通过经腹超声、CT、内镜超声(EUS)和MRI对假性囊肿进行成像。EUS相对于其他成像方式具有优势,因为某些EUS特征提示为假性囊肿而非其他囊性病变。使用EUS引导下细针穿刺进一步提高了EUS的诊断准确性。治疗选择包括密切观察或干预。我们认为,如果急性假性囊肿无并发症、无症状且在系列成像中未显示增大,则最好不进行干预,因为许多此类囊肿会自行消退。然而,需要警惕未消退的假性囊肿发生感染等并发症的可能性。与慢性胰腺炎相关的假性囊肿自发消退的可能性较小,更常通过干预进行引流。在三种干预选项中,即内镜、经皮和手术引流,如果符合某些标准,内镜引流应作为首选治疗方法。介入前必须进行内镜逆行胰胆管造影以明确导管解剖结构。如果假性囊肿与胰管相通,则首选经乳头途径。使用EUS应增加可通过内镜引流假性囊肿的病例数量。手术应保留用于怀疑有恶性肿瘤或存在腺体破坏的病例。